[HTML][HTML] Emerging anti-cancer molecular mechanisms of aminobisphosphonates
M Caraglia, D Santini, M Marra… - Endocrine-related …, 2006 - erc.bioscientifica.com
Bone metastases are common in patients with many types of cancer, especially breast and
prostate cancer—in which the incidence is approximately 70% among patients with …
prostate cancer—in which the incidence is approximately 70% among patients with …
[PDF][PDF] Emerging anti-cancer molecular mechanisms of aminobisphosphonates
M Caraglia, D Santini, M Marra, B Vincenzi… - Endocrine-Related …, 2006 - Citeseer
Bone metastases are common in patients with many types of cancer, especially breast and
prostate cancer—in which the incidence is approximately 70% among patients with …
prostate cancer—in which the incidence is approximately 70% among patients with …
[引用][C] Emerging anti-cancer molecular mechanisms of aminobisphosphonates
M Caraglia, D Santini, M Marra… - ENDOCRINE …, 2006 - iris.unicampania.it
[PDF][PDF] Emerging anti-cancer molecular mechanisms of aminobisphosphonates
M Caraglia, D Santini, M Marra, B Vincenzi… - Endocrine-Related …, 2006 - researchgate.net
Bone metastases are common in patients with many types of cancer, especially breast and
prostate cancer—in which the incidence is approximately 70% among patients with …
prostate cancer—in which the incidence is approximately 70% among patients with …
Emerging anti-cancer molecular mechanisms of aminobisphosphonates
M Caraglia, D Santini, M Marra… - Endocrine-related …, 2006 - pubmed.ncbi.nlm.nih.gov
Bone metastases are common in patients with many types of cancer, especially breast and
prostate cancer--in which the incidence is approximately 70% among patients with …
prostate cancer--in which the incidence is approximately 70% among patients with …
Emerging anti-cancer molecular mechanisms of aminobisphosphonates
M Caraglia, D Santini, M Marra, B Vincenzi… - ENDOCRINE …, 2006 - iris.unicampus.it
Bone metastases are common in patients with many types of cancer, especially breast and
prostatecancer—in which the incidence is approximately 70% among patients with …
prostatecancer—in which the incidence is approximately 70% among patients with …
Emerging anti-cancer molecular mechanisms of aminobisphosphonates.
M Caraglia, D Santini, M Marra, B Vincenzi… - Endocrine-related …, 2006 - europepmc.org
Bone metastases are common in patients with many types of cancer, especially breast and
prostate cancer--in which the incidence is approximately 70% among patients with …
prostate cancer--in which the incidence is approximately 70% among patients with …
[PDF][PDF] Emerging anti-cancer molecular mechanisms of aminobisphosphonates
M Caraglia, D Santini, M Marra… - Endocrine-Related …, 2006 - scholar.archive.org
Bone metastases are common in patients with many types of cancer, especially breast and
prostate cancer—in which the incidence is approximately 70% among patients with …
prostate cancer—in which the incidence is approximately 70% among patients with …
[PDF][PDF] Emerging anti-cancer molecular mechanisms of aminobisphosphonates
M Caraglia, D Santini, M Marra… - Endocrine …, 2006 - publicationslist.org.s3.amazonaws …
Bone metastases are common in patients with many types of cancer, especially breast and
prostate cancer—in which the incidence is approximately 70% among patients with …
prostate cancer—in which the incidence is approximately 70% among patients with …
[PDF][PDF] Emerging anti-cancer molecular mechanisms of aminobisphosphonates
M Caraglia, D Santini, M Marra, B Vincenzi… - Endocrine-Related …, 2006 - academia.edu
Bone metastases are common in patients with many types of cancer, especially breast and
prostate cancer—in which the incidence is approximately 70% among patients with …
prostate cancer—in which the incidence is approximately 70% among patients with …